Stephen
CSO
ADVISORY BOARD
Savira Pharmaceuticals
Austria
Biography
Stephen Cusack has been group leader and head of the EMBL Grenoble outstation since 1989. Stephen Cusack received his PhD in 1976 from the Imperial College, London, UK. Postdoctoral work led him to EMBL Grenoble, France, where he worked as staff scientist 1980–1989. The Cusack group is engaged in structural biology research of RNA-protein complexes in gene expression and host-pathogen interactions. Stephen Cusack has an outstanding track record in structural biology. Current research included the field of influenza virus research, leading to elucidation of crucial viral functional domains and the crystallographic structural analysis using the powerful X-ray beams of the European Synchrotron Radiation Facility (ESRF). The most recent results, forming the basis for Savira’s foundation, led to the corresponding patents and two key publications in Nature Structural and Molecular Biology. Stephen Cusack has been group leader and head of the EMBL Grenoble outstation since 1989. Stephen Cusack received his PhD in 1976 from the Imperial College, London, UK. Postdoctoral work led him to EMBL Grenoble, France, where he worked as staff scientist 1980–1989. The Cusack group is engaged in structural biology research of RNA-protein complexes in gene expression and host-pathogen interactions. Stephen Cusack has an outstanding track record in structural biology. Current research included the field of influenza virus research, leading to elucidation of crucial viral functional domains and the crystallographic structural analysis using the powerful X-ray beams of the European Synchrotron Radiation Facility (ESRF). The most recent results, forming the basis for Savira’s foundation, led to the corresponding patents and two key publications in Nature Structural and Molecular Biology.
Research Interest
Molecular Biology.